English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Due to the development of digital technologies and their integration into all spheres of everyday and professional life, including healthcare, the analysis of the current digital solutions for doctors and patients, the discussion of the issues of scientific and clinical justification and regulatory regulation of their use became extremely important. Significant imbalance between the avalanche increase in technical capabilities and their slow implementation in routine clinical practice is becoming the challenge to the medical community.   The pandemic of the new COVID-19 virus infection associated with SARS-CoV-2, in addition to the obvious problems in the combination to the rapid spread and severe course of the disease, served as a trigger for the re-evaluation of the role of remote medical care, as well as re-estimation of the approaches to the selection of medications, in particular hypoglycemic and antihypertensive drugs, in terms of their possible impact on the course and prognosis of COVID-19 in patients with type 2 diabetes

COVID-19 Pandemic As the Trigger for Correction of the Approaches to Management Type 2 Diabetes